Impact of COVID-19 Outbreak on Kidney Disease Drugs, Global Market Research Report 2020

Impact of COVID-19 Outbreak on Kidney Disease Drugs, Global Market Research Report 2020

Table of Contents
1 Kidney Disease Drugs Market Overview
1.1 Product Overview and Scope of Kidney Disease Drugs
1.2 Covid-19 Implications on Kidney Disease Drugs Segment by Type
1.2.1 Global Kidney Disease Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Other
1.3 Covid-19 Implications on Kidney Disease Drugs Segment by Application
1.3.1 Kidney Disease Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Chronic Glomerulonephritis
1.3.3 Nephrotic Syndrome
1.3.4 Chronic Renal Failure
1.3.5 Kidney Stones
1.3.6 Renal Cyst (polycystic Kidney)
1.3.7 Diabetic Nephropathy
1.3.8 Hypertensive Nephropathy
1.3.9 Purpura Nephritis
1.3.10 Lupus Nephritis
1.3.11 Pediatric Kidney Disease
1.4 Covid-19 Implications on Global Kidney Disease Drugs Market Size Estimates and Forecasts
1.4.1 Global Kidney Disease Drugs Revenue 2015-2026
1.4.2 Global Kidney Disease Drugs Sales 2015-2026
1.4.3 Kidney Disease Drugs Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Kidney Disease Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Kidney Disease Drugs Industry
1.5.1.1 Kidney Disease Drugs Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Kidney Disease Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Kidney Disease Drugs Players to Combat Covid-19 Impact
2 Covid-19 Implications on Global Kidney Disease Drugs Market Competition by Manufacturers
2.1 Global Kidney Disease Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Kidney Disease Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Kidney Disease Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Kidney Disease Drugs Manufacturing Sites, Area Served, Product Type
2.5 Kidney Disease Drugs Market Competitive Situation and Trends
2.5.1 Kidney Disease Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Kidney Disease Drugs Players (Opinion Leaders)
3 Covid-19 Implications on Kidney Disease Drugs Retrospective Market Scenario by Region
3.1 Global Kidney Disease Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Kidney Disease Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Kidney Disease Drugs Market Facts & Figures by Country
3.3.1 North America Kidney Disease Drugs Sales by Country
3.3.2 North America Kidney Disease Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Kidney Disease Drugs Market Facts & Figures by Country
3.4.1 Europe Kidney Disease Drugs Sales by Country
3.4.2 Europe Kidney Disease Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Kidney Disease Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Kidney Disease Drugs Sales by Region
3.5.2 Asia Pacific Kidney Disease Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Kidney Disease Drugs Market Facts & Figures by Country
3.6.1 Latin America Kidney Disease Drugs Sales by Country
3.6.2 Latin America Kidney Disease Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Kidney Disease Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Kidney Disease Drugs Sales by Country
3.7.2 Middle East and Africa Kidney Disease Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Kidney Disease Drugs Historic Market Analysis by Type
4.1 Global Kidney Disease Drugs Sales Market Share by Type (2015-2020)
4.2 Global Kidney Disease Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Kidney Disease Drugs Price Market Share by Type (2015-2020)
4.4 Global Kidney Disease Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Kidney Disease Drugs Historic Market Analysis by Application
5.1 Global Kidney Disease Drugs Sales Market Share by Application (2015-2020)
5.2 Global Kidney Disease Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Kidney Disease Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Kidney Disease Drugs Business
6.1 GlaxoSmithKline
6.1.1 Corporation Information
6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GlaxoSmithKline Products Offered
6.1.5 GlaxoSmithKline Recent Development
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description, Business Overview and Total Revenue
6.2.3 Sanofi Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sanofi Products Offered
6.2.5 Sanofi Recent Development
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description, Business Overview and Total Revenue
6.3.3 Roche Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Roche Products Offered
6.3.5 Roche Recent Development
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description, Business Overview and Total Revenue
6.4.3 Pfizer Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer Products Offered
6.4.5 Pfizer Recent Development
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description, Business Overview and Total Revenue
6.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 AstraZeneca Products Offered
6.5.5 AstraZeneca Recent Development
6.6 Keryx Biopharmaceuticals
6.6.1 Keryx Biopharmaceuticals Corporation Information
6.6.2 Keryx Biopharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Keryx Biopharmaceuticals Products Offered
6.6.5 Keryx Biopharmaceuticals Recent Development
6.7 Kissei Pharmaceutical
6.6.1 Kissei Pharmaceutical Corporation Information
6.6.2 Kissei Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Kissei Pharmaceutical Products Offered
6.7.5 Kissei Pharmaceutical Recent Development
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description, Business Overview and Total Revenue
6.8.3 AbbVie Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 AbbVie Products Offered
6.8.5 AbbVie Recent Development
6.9 Amgen
6.9.1 Amgen Corporation Information
6.9.2 Amgen Description, Business Overview and Total Revenue
6.9.3 Amgen Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Amgen Products Offered
6.9.5 Amgen Recent Development
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Corporation Information
6.10.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
6.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Teva Pharmaceutical Industries Products Offered
6.10.5 Teva Pharmaceutical Industries Recent Development
6.11 Tianjin Tongrentang Group
6.11.1 Tianjin Tongrentang Group Corporation Information
6.11.2 Tianjin Tongrentang Group Kidney Disease Drugs Description, Business Overview and Total Revenue
6.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Tianjin Tongrentang Group Products Offered
6.11.5 Tianjin Tongrentang Group Recent Development
6.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
6.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
6.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Description, Business Overview and Total Revenue
6.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Products Offered
6.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development
6.13 Datong Liqun Pharmaceutical
6.13.1 Datong Liqun Pharmaceutical Corporation Information
6.13.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Description, Business Overview and Total Revenue
6.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Datong Liqun Pharmaceutical Products Offered
6.13.5 Datong Liqun Pharmaceutical Recent Development
6.14 Hebei Ruisen Pharmaceutical
6.14.1 Hebei Ruisen Pharmaceutical Corporation Information
6.14.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Description, Business Overview and Total Revenue
6.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Hebei Ruisen Pharmaceutical Products Offered
6.14.5 Hebei Ruisen Pharmaceutical Recent Development
6.15 Changxing Pharmaceutical
6.15.1 Changxing Pharmaceutical Corporation Information
6.15.2 Changxing Pharmaceutical Kidney Disease Drugs Description, Business Overview and Total Revenue
6.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Changxing Pharmaceutical Products Offered
6.15.5 Changxing Pharmaceutical Recent Development
6.16 zhejiang Shengbokang Pharmaceutical
6.16.1 zhejiang Shengbokang Pharmaceutical Corporation Information
6.16.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Description, Business Overview and Total Revenue
6.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 zhejiang Shengbokang Pharmaceutical Products Offered
6.16.5 zhejiang Shengbokang Pharmaceutical Recent Development
7 Kidney Disease Drugs Manufacturing Cost Analysis
7.1 Kidney Disease Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Kidney Disease Drugs
7.4 Kidney Disease Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Kidney Disease Drugs Distributors List
8.3 Kidney Disease Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Kidney Disease Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Kidney Disease Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Kidney Disease Drugs by Type (2021-2026)
10.2 Kidney Disease Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Kidney Disease Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Kidney Disease Drugs by Application (2021-2026)
10.3 Kidney Disease Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Kidney Disease Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Kidney Disease Drugs by Region (2021-2026)
10.4 North America Kidney Disease Drugs Estimates and Projections (2021-2026)
10.5 Europe Kidney Disease Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Kidney Disease Drugs Estimates and Projections (2021-2026)
10.7 Latin America Kidney Disease Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Kidney Disease Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Kidney Disease Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Kidney Disease Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Kidney Disease Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Kidney Disease Drugs Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Kidney Disease Drugs Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Kidney Disease Drugs Players to Combat Covid-19 Impact
Table 9. Global Key Kidney Disease Drugs Manufacturers Covered in This Study
Table 10. Global Kidney Disease Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Kidney Disease Drugs Sales Share by Manufacturers (2015-2020)
Table 12. Global Kidney Disease Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Kidney Disease Drugs Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Kidney Disease Drugs Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Kidney Disease Drugs Sales Sites and Area Served
Table 16. Manufacturers Kidney Disease Drugs Product Types
Table 17. Global Kidney Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Disease Drugs as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Kidney Disease Drugs Players
Table 21. Global Kidney Disease Drugs Sales (K Units) by Region (2015-2020)
Table 22. Global Kidney Disease Drugs Sales Market Share by Region (2015-2020)
Table 23. Global Kidney Disease Drugs Revenue (Million US$) by Region (2015-2020)
Table 24. Global Kidney Disease Drugs Revenue Market Share by Region (2015-2020)
Table 25. North America Kidney Disease Drugs Sales by Country (2015-2020) (K Units)
Table 26. North America Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 27. North America Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 29. Europe Kidney Disease Drugs Sales by Country (2015-2020) (K Units)
Table 30. Europe Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 31. Europe Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Kidney Disease Drugs Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Kidney Disease Drugs Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Kidney Disease Drugs Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Kidney Disease Drugs Revenue Market Share by Region (2015-2020)
Table 37. Latin America Kidney Disease Drugs Sales by Country (2015-2020) (K Units)
Table 38. Latin America Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 39. Latin America Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Kidney Disease Drugs Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 45. Global Kidney Disease Drugs Sales (K Units) by Type (2015-2020)
Table 46. Global Kidney Disease Drugs Sales Share by Type (2015-2020)
Table 47. Global Kidney Disease Drugs Revenue (Million US$) by Type (2015-2020)
Table 48. Global Kidney Disease Drugs Revenue Share by Type (2015-2020)
Table 49. Global Kidney Disease Drugs Price (US$/Unit) by Type (2015-2020)
Table 50. Global Kidney Disease Drugs Sales (K Units) by Application (2015-2020)
Table 51. Global Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 52. Global Kidney Disease Drugs Sales Growth Rate by Application (2015-2020)
Table 53. GlaxoSmithKline Kidney Disease Drugs Corporation Information
Table 54. GlaxoSmithKline Description and Business Overview
Table 55. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. GlaxoSmithKline Main Product
Table 57. GlaxoSmithKline Recent Development
Table 58. Sanofi Kidney Disease Drugs Corporation Information
Table 59. Sanofi Corporation Information
Table 60. Sanofi Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Sanofi Main Product
Table 62. Sanofi Recent Development
Table 63. Roche Kidney Disease Drugs Corporation Information
Table 64. Roche Corporation Information
Table 65. Roche Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Roche Main Product
Table 67. Roche Recent Development
Table 68. Pfizer Kidney Disease Drugs Corporation Information
Table 69. Pfizer Corporation Information
Table 70. Pfizer Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Pfizer Main Product
Table 72. Pfizer Recent Development
Table 73. AstraZeneca Kidney Disease Drugs Corporation Information
Table 74. AstraZeneca Corporation Information
Table 75. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. AstraZeneca Main Product
Table 77. AstraZeneca Recent Development
Table 78. Keryx Biopharmaceuticals Kidney Disease Drugs Corporation Information
Table 79. Keryx Biopharmaceuticals Corporation Information
Table 80. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Keryx Biopharmaceuticals Main Product
Table 82. Keryx Biopharmaceuticals Recent Development
Table 83. Kissei Pharmaceutical Kidney Disease Drugs Corporation Information
Table 84. Kissei Pharmaceutical Corporation Information
Table 85. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Kissei Pharmaceutical Main Product
Table 87. Kissei Pharmaceutical Recent Development
Table 88. AbbVie Kidney Disease Drugs Corporation Information
Table 89. AbbVie Corporation Information
Table 90. AbbVie Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. AbbVie Main Product
Table 92. AbbVie Recent Development
Table 93. Amgen Kidney Disease Drugs Corporation Information
Table 94. Amgen Corporation Information
Table 95. Amgen Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Amgen Main Product
Table 97. Amgen Recent Development
Table 98. Teva Pharmaceutical Industries Kidney Disease Drugs Corporation Information
Table 99. Teva Pharmaceutical Industries Corporation Information
Table 100. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Teva Pharmaceutical Industries Main Product
Table 102. Teva Pharmaceutical Industries Recent Development
Table 103. Tianjin Tongrentang Group Kidney Disease Drugs Corporation Information
Table 104. Tianjin Tongrentang Group Corporation Information
Table 105. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Tianjin Tongrentang Group Main Product
Table 107. Tianjin Tongrentang Group Recent Development
Table 108. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Corporation Information
Table 109. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
Table 110. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Main Product
Table 112. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development
Table 113. Datong Liqun Pharmaceutical Kidney Disease Drugs Corporation Information
Table 114. Datong Liqun Pharmaceutical Corporation Information
Table 115. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Datong Liqun Pharmaceutical Main Product
Table 117. Datong Liqun Pharmaceutical Recent Development
Table 118. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Corporation Information
Table 119. Hebei Ruisen Pharmaceutical Corporation Information
Table 120. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. Hebei Ruisen Pharmaceutical Main Product
Table 122. Hebei Ruisen Pharmaceutical Recent Development
Table 123. Changxing Pharmaceutical Kidney Disease Drugs Corporation Information
Table 124. Changxing Pharmaceutical Corporation Information
Table 125. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 126. Changxing Pharmaceutical Main Product
Table 127. Changxing Pharmaceutical Recent Development
Table 128. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Corporation Information
Table 129. zhejiang Shengbokang Pharmaceutical Corporation Information
Table 130. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. zhejiang Shengbokang Pharmaceutical Main Product
Table 132. zhejiang Shengbokang Pharmaceutical Recent Development
Table 133. Sales Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Kidney Disease Drugs Distributors List
Table 136. Kidney Disease Drugs Customers List
Table 137. Market Key Trends
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Global Kidney Disease Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 141. Global Kidney Disease Drugs Sales Market Share Forecast by Type (2021-2026)
Table 142. Global Kidney Disease Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 143. Global Kidney Disease Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 144. Global Kidney Disease Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 145. Global Kidney Disease Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 146. Global Kidney Disease Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 147. Global Kidney Disease Drugs Sales Market Share Forecast by Region (2021-2026)
Table 148. Global Kidney Disease Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Global Kidney Disease Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Kidney Disease Drugs
Figure 2. Global Kidney Disease Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Tablets Product Picture
Figure 4. Capsule Product Picture
Figure 5. Other Product Picture
Figure 6. Global Kidney Disease Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 7. Chronic Glomerulonephritis
Figure 8. Nephrotic Syndrome
Figure 9. Chronic Renal Failure
Figure 10. Kidney Stones
Figure 11. Renal Cyst (polycystic Kidney)
Figure 12. Diabetic Nephropathy
Figure 13. Hypertensive Nephropathy
Figure 14. Purpura Nephritis
Figure 15. Lupus Nephritis
Figure 16. Pediatric Kidney Disease
Figure 17. Global Kidney Disease Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Kidney Disease Drugs Sales Capacity (K Units) (2015-2026)
Figure 19. Global Kidney Disease Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Kidney Disease Drugs Sales Share by Manufacturers in 2020
Figure 21. Global Kidney Disease Drugs Revenue Share by Manufacturers in 2019
Figure 22. The Global 5 and 10 Largest Players: Market Share by Kidney Disease Drugs Revenue in 2019
Figure 23. Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Kidney Disease Drugs Sales Market Share by Region (2015-2020)
Figure 25. Global Kidney Disease Drugs Sales Market Share by Region in 2019
Figure 26. Global Kidney Disease Drugs Revenue Market Share by Region (2015-2020)
Figure 27. Global Kidney Disease Drugs Revenue Market Share by Region in 2019
Figure 28. North America Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 29. North America Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 30. U.S. Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. U.S. Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. Canada Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. Canada Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Europe Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 35. Europe Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 36. Germany Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Germany Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. France Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. France Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. U.K. Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.K. Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Italy Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Italy Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Russia Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Russia Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Asia Pacific Kidney Disease Drugs Sales Market Share by Region in 2019
Figure 47. Asia Pacific Kidney Disease Drugs Revenue Market Share by Region in 2019
Figure 48. China Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. China Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Japan Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Japan Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. South Korea Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. South Korea Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. India Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. India Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Australia Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Australia Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Taiwan Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Taiwan Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Indonesia Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Indonesia Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Thailand Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Thailand Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Malaysia Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Malaysia Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Philippines Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Philippines Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Vietnam Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Vietnam Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Latin America Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 71. Latin America Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 72. Mexico Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Mexico Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Brazil Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Brazil Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Argentina Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Middle East and Africa Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 79. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 80. Turkey Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Saudi Arabia Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Saudi Arabia Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. UAE Kidney Disease Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. UAE Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Sales Market Share of Kidney Disease Drugs by Type (2015-2020)
Figure 87. Sales Market Share of Kidney Disease Drugs by Type in 2019
Figure 88. Revenue Share of Kidney Disease Drugs by Type (2015-2020)
Figure 89. Revenue Market Share of Kidney Disease Drugs by Type in 2019
Figure 90. Global Kidney Disease Drugs Sales Growth by Type (2015-2020) (K Units)
Figure 91. Global Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Figure 92. Global Kidney Disease Drugs Sales Market Share by Application in 2019
Figure 93. Global Revenue Share of Kidney Disease Drugs by Application (2015-2020)
Figure 94. Global Revenue Share of Kidney Disease Drugs by Application in 2020
Figure 95. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Keryx Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Kissei Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Tianjin Tongrentang Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Datong Liqun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Hebei Ruisen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Changxing Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. zhejiang Shengbokang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Price Trend of Key Raw Materia

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs